000220 — Yuyu Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩76bn
- KR₩80bn
- KR₩133bn
- 48
- 83
- 82
- 84
Annual cashflow statement for Yuyu Pharma, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 2,413 | -920 | -4,425 | -5,541 | 10,289 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 5,050 | 4,604 | 6,693 | 7,380 | 3,307 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -14,031 | -3,678 | -13,524 | -7,026 | 5,688 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2,669 | 4,509 | -6,229 | 421 | 24,950 |
| Capital Expenditures | -14,289 | -6,751 | -5,568 | -5,106 | -7,304 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 2,148 | 861 | -2,976 | 2,291 | 3,295 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -12,142 | -5,890 | -8,544 | -2,815 | -4,009 |
| Financing Cash Flow Items | -203 | -225 | -380 | -549 | -830 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 8,511 | 31,313 | -9,083 | 7,160 | -9,860 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -6,523 | 29,941 | -24,425 | 4,766 | 11,228 |